Hussman Strategic Advisors, Inc. Gilead Sciences, Inc. Transaction History

Hussman Strategic Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $325,336 - $354,948	4,400 Added 11.7%	42,000 $3.15 Million
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $972,928 - $1.11 Million	12,800 Added 51.61%	37,600 $2.9 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $398,848 - $572,608	-6,400 Reduced 20.51%	24,800 $2.13 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $2.02 Million - $2.3 Million	31,200 New	31,200 $2.27 Million
Q1 2021 May 03, 2021	SELL	$60.0 - $68.46 $1.22 Million - $1.4 Million	-20,400 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $1.16 Million - $1.32 Million	20,400 New	20,400 $1.19 Million
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $2.98 Million - $3.46 Million	-41,150 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $2.58 Million - $3.3 Million	41,150 New	41,150 $3.08 Million
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $50,024 - $56,040	-800 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $1.51 Million - $1.98 Million	-25,000 Reduced 96.9%	800 $50,000
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $1.78 Million - $1.97 Million	-25,000 Reduced 49.21%	25,800 $1.99 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $3.7 Million - $4.51 Million	50,800 New	50,800 $3.83 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.